0001628280-24-029949.txt : 20240625 0001628280-24-029949.hdr.sgml : 20240625 20240625182229 ACCESSION NUMBER: 0001628280-24-029949 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240621 FILED AS OF DATE: 20240625 DATE AS OF CHANGE: 20240625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blanks Robert CENTRAL INDEX KEY: 0001815433 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36485 FILM NUMBER: 241070179 MAIL ADDRESS: STREET 1: C/O ARDELYX STREET 2: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARDELYX, INC. CENTRAL INDEX KEY: 0001437402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-7047 MAIL ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: NTERYX INC DATE OF NAME CHANGE: 20080611 4 1 wk-form4_1719354142.xml FORM 4 X0508 4 2024-06-21 0 0001437402 ARDELYX, INC. ARDX 0001815433 Blanks Robert C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210 WALTHAM MA 02451 0 1 0 0 See Remarks 1 Common Stock 2024-06-21 4 S 0 38000 5.955 D 324331 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2023. Transaction was executed in multiple trades in prices ranging from $5.91 to $6.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Chief Regulatory and Quality Affairs Officer /s/ Elizabeth Grammer, Attorney-in-Fact for Robert Blanks 2024-06-25